Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan.
Department of Emergency Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Resuscitation. 2019 Oct;143:165-172. doi: 10.1016/j.resuscitation.2019.07.002. Epub 2019 Jul 11.
This study aimed to evaluate whether intra-aortic balloon pump (IABP) use in nontraumatic out-of-hospital cardiac arrest (OHCA) patients who achieved return of spontaneous circulation (ROSC) is associated with favorable neurological outcome after OHCA.
The association between the IABP use in OHCA patients and favorable neurological outcome has not been extensively evaluated.
The Comprehensive Registry of Intensive Cares for OHCA Survival (CRITICAL) study, a multicenter, prospective observational registry in Osaka, Japan, included consecutive nontraumatic OHCA patients aged ≥18 years who achieved ROSC from July 2012 to December 2016. The primary outcome was 1-month survival with favorable neurological outcome. Logistic regression analysis was used to evaluate the association between the IABP use or non-IABP use and favorable neurological outcome using one-to-one propensity score (PS) matching analysis.
Among the 2894 eligible patients, 10.4% used IABP, and 89.6% did not use IABP. In all patients, the proportion of 1-month survival with favorable neurological outcome was higher in the IABP use group than in the non-IABP use group (30.7% [92/300] vs. 13.2% [342/2594]). However, in PS-matched patients, the proportions of 1-month survival with favorable neurological outcome were almost consistent, and there were no significant differences between the IABP use group and the non-IABP use group (37.3% [59/158] vs. 41.1% [65/158]; adjusted odds ratio, 0.97; 95% confidence interval, 0.48-1.96).
In this population, the current PS matching analysis did not reveal any association between the IABP use and 1-month survival with favorable neurological outcome among adult patients with ROSC after OHCA.
本研究旨在评估在非创伤性院外心脏骤停(OHCA)患者中,成功恢复自主循环(ROSC)后使用主动脉内球囊反搏(IABP)是否与 OHCA 后的良好神经功能结局相关。
IABP 在 OHCA 患者中的使用与良好的神经功能结局之间的关联尚未得到广泛评估。
日本大阪多中心前瞻性观察性登记研究——综合重症监护 OHCA 生存登记研究(CRITICAL)纳入了 2012 年 7 月至 2016 年 12 月期间年龄≥18 岁、成功恢复 ROSC 的连续非创伤性 OHCA 患者。主要结局为 1 个月时存活且具有良好神经功能结局。使用 1:1 倾向评分(PS)匹配分析的逻辑回归分析评估 IABP 使用与非 IABP 使用与良好神经功能结局之间的关联。
在 2894 例符合条件的患者中,10.4%使用了 IABP,89.6%未使用 IABP。在所有患者中,IABP 使用组的 1 个月时存活且具有良好神经功能结局的比例高于非 IABP 使用组(30.7%[92/300] vs. 13.2%[342/2594])。然而,在 PS 匹配患者中,1 个月时存活且具有良好神经功能结局的比例几乎一致,IABP 使用组与非 IABP 使用组之间无显著差异(37.3%[59/158] vs. 41.1%[65/158];调整后的优势比,0.97;95%置信区间,0.48-1.96)。
在本人群中,目前的 PS 匹配分析并未显示在 ROSC 后 OHCA 成年患者中,IABP 使用与 1 个月时存活且具有良好神经功能结局之间存在关联。